Streamline Health Solutions, Inc. (STRM) Key Metrics
STRM valuation today
Trailing 12 months · as of July 26, 2026- Market cap
- $23.2M
- Enterprise value
- $35.8M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 1.3
- Price / book
- 2.1
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 2.08
STRM key metrics, FY2016–FY2025
Fiscal year ended January 31, 2025 · U.S. dollarsSTRM returns How much profit the business earns on the capital it uses.
Return on equity+3.5 pts
−65.4%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Return on invested capital+22.2 pts
−25.7%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Return on assets+9.9 pts
−26.3%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow margin+3.7 pts
−13.3%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Asset turnover+5.8%
0.46
FY2025 · hover or tap a bar for each year
FY2016FY2025
STRM per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−40.4%
$4.47
FY2025 · hover or tap a bar for each year
FY2016FY2025
Earnings per share
−$2.53
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow per share
−$0.59
FY2025 · hover or tap a bar for each year
FY2016FY2025
Book value per share−50.9%
$3.06
FY2025 · hover or tap a bar for each year
FY2016FY2025
Shares outstanding+32.8%
4.0M
FY2025 · hover or tap a bar for each year
FY2016FY2025
STRM financial health Debt, liquidity and how easily interest is covered.
Debt / equity+90.3%
1.07
FY2025 · hover or tap a bar for each year
FY2016FY2025
Net debt+$3.6M
$10.9M
FY2025 · hover or tap a bar for each year
FY2016FY2025
Current ratio−61.2%
0.25
FY2025 · hover or tap a bar for each year
FY2016FY2025
Interest coverage
-4.0
FY2025 · hover or tap a bar for each year
FY2016FY2025
Debt / assets+45.7%
0.37
FY2025 · hover or tap a bar for each year
FY2016FY2025
STRM efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−27 days
83 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
Days payables outstanding+22 days
53 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
Cash conversion cycle−50 days
30 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
Capex / revenue−2.4 pts
4.8%
FY2025 · hover or tap a bar for each year
FY2016FY2025
STRM returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
STRM debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
STRM cash returned to shareholders
DividendsBuybacksFree cash flow
STRM key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Per share | ||||||||||
| Revenue per share | $4.47 | $7.49 | $8.25 | $5.76 | $3.76 | $12.40 | $17.17 | $19.12 | $20.79 | $22.72 |
| Earnings per share | −$2.53 | −$6.20 | −$3.77 | −$2.29 | −$1.59 | −$1.71 | −$4.50 | −$2.44 | −$3.96 | −$3.44 |
| Operating cash flow per share | −$0.38 | −$0.73 | −$2.37 | −$1.16 | −$1.91 | −$0.00 | $1.07 | $1.60 | $0.77 | $4.72 |
| Free cash flow per share | −$0.59 | −$1.27 | −$3.01 | −$1.66 | −$2.51 | −$2.04 | −$1.25 | $0.11 | −$1.13 | $4.30 |
| Cash per share | $0.54 | $1.06 | $2.19 | $3.28 | $0.80 | $0.99 | $1.82 | $3.63 | $4.34 | $7.93 |
| Book value per share | $3.06 | $6.23 | $11.77 | $11.28 | $5.80 | $9.57 | $11.43 | $14.69 | $15.89 | $19.26 |
| Tangible book value per share | −$4.06 | −$4.09 | −$2.72 | −$3.77 | $0.07 | −$4.93 | −$6.15 | −$5.48 | −$4.94 | −$5.19 |
| Dividends per share | — | — | — | — | — | $2.34 | — | $0.00 | $0.00 | $0.00 |
| Capex per share | $0.21 | $0.54 | $0.64 | $0.50 | $0.61 | $2.04 | $2.32 | $1.48 | $1.91 | $0.42 |
| Debt per share | $3.27 | $3.50 | $3.23 | $3.36 | $0.90 | $2.29 | $3.03 | $3.75 | $4.59 | $7.70 |
| Shares outstanding | 4.0M | 3.0M | 3.0M | 3.0M | 3.0M | 1.7M | 1.3M | 1.3M | 1.3M | 1.2M |
| Change in shares outstanding | +32.8% | 0.0% | 0.0% | 0.0% | +80.5% | +28.4% | +2.4% | −2.2% | +4.5% | +2.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −65.4% | −68.8% | −32.7% | −26.8% | −28.7% | −18.5% | −34.9% | −15.7% | −23.1% | −17.3% |
| Return on invested capital (ROIC) | −25.7% | −47.9% | −23.5% | −32.7% | −25.6% | −6.9% | −23.7% | −10.4% | −16.9% | −16.3% |
| Return on assets (ROA) | −26.3% | −36.2% | −18.5% | −15.8% | −16.7% | −9.0% | −17.0% | −7.9% | −11.2% | −8.1% |
| Return on tangible assets | −144.8% | −176.6% | −64.0% | −42.2% | −55.2% | −38.7% | −66.4% | −27.1% | −35.5% | −21.8% |
| Free cash flow margin | −13.3% | −17.0% | −36.5% | −28.8% | −66.9% | −16.5% | −7.3% | 0.6% | −5.5% | 18.9% |
| Financial health | ||||||||||
| Total debt | $13.1M | $10.6M | $9.7M | $10.1M | $2.7M | $3.8M | $3.9M | $4.8M | $6.0M | $9.6M |
| Cash & short-term investments | $2.2M | $3.2M | $6.6M | $9.9M | $2.4M | $1.6M | $2.4M | $4.6M | $5.7M | $9.9M |
| Net debt | $10.9M | $7.4M | $3.2M | $256,000 | $312,000 | $2.2M | $1.6M | $152,631 | $316,010 | −$291,940 |
| Debt / equity | 1.07 | 0.56 | 0.27 | 0.30 | 0.16 | 0.24 | 0.27 | 0.26 | 0.29 | 0.40 |
| Debt / assets | 0.37 | 0.25 | 0.16 | 0.16 | 0.10 | 0.12 | 0.12 | 0.13 | 0.14 | 0.19 |
| Net debt / EBITDA | — | — | — | — | — | — | — | 0.11 | 0.57 | −0.13 |
| Current ratio | 0.25 | 0.65 | 0.95 | 1.12 | 0.99 | 0.42 | 0.65 | 0.84 | 0.94 | 1.15 |
| Quick ratio | 0.25 | 0.65 | 0.95 | 1.12 | 0.80 | 0.42 | 0.58 | 0.73 | 0.83 | 1.01 |
| Interest coverage | -4.0 | -18.3 | -14.5 | -45.6 | -114.5 | -4.9 | -13.8 | -5.5 | -9.4 | -6.4 |
| Working capital | −$17.3M | −$4.8M | −$788,000 | $1.6M | −$54,000 | −$9.0M | −$4.2M | −$1.8M | −$816,486 | $2.1M |
| Invested capital | $23.2M | $26.2M | $38.7M | $34.3M | $17.8M | $18.2M | $16.5M | $18.9M | $21.0M | $23.7M |
| Tangible asset value | −$16.3M | −$12.3M | −$8.2M | −$11.4M | $208,000 | −$8.2M | −$14.2M | −$7.0M | −$6.4M | −$6.5M |
| Net current asset value | −$17.5M | −$14.1M | −$10.0M | −$12.7M | −$1.2M | −$9.1M | −$15.1M | −$8.8M | −$9.0M | −$9.9M |
| Graham net-net per share | −$4.68 | −$5.29 | −$4.28 | −$4.77 | −$1.01 | −$7.11 | −$13.11 | −$8.46 | −$8.38 | −$9.69 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | $3.9M | — | $0 | $0 | $0 |
| Share buybacks (net) | — | — | $0 | $1.3M | $1.3M | $5.8M | $0 | $0 | $0 | $0 |
| Dividends + buybacks / free cash flow | — | — | — | — | — | — | — | 0.0% | — | 0.0% |
| Capex / revenue | 4.8% | 7.2% | 7.8% | 8.6% | 16.1% | 16.4% | 13.5% | 7.7% | 9.2% | 1.8% |
| Capex / operating cash flow | — | — | — | — | — | — | 216.5% | 92.8% | 246.5% | 8.8% |
| Capex / depreciation | 0.18 | 0.37 | 0.45 | 0.41 | 0.71 | 1.59 | 1.19 | 0.47 | 0.48 | 0.09 |
| Stock-based compensation / revenue | 11.0% | 9.3% | 6.7% | 12.8% | 12.4% | 4.5% | 2.8% | 4.6% | 6.6% | 8.4% |
| R&D / revenue | 25.9% | 36.1% | 24.3% | 27.5% | 25.9% | 17.1% | 19.1% | 22.0% | 27.5% | 32.1% |
| SG&A / revenue | 65.6% | 65.1% | 64.8% | 68.7% | 75.5% | 49.2% | 51.8% | 47.0% | 48.4% | 47.5% |
| Efficiency | ||||||||||
| Days sales outstanding | 83.3 | 110.6 | 97.9 | 81.6 | 95.3 | 61.7 | 60.6 | 61.3 | 62.6 | 73.8 |
| Days of inventory on hand | — | — | 0.0 | 29.5 | 89.0 | — | 48.4 | 46.4 | 51.3 | 72.9 |
| Days payables outstanding | 53.3 | 31.0 | 19.1 | 22.3 | 33.0 | 49.7 | 38.2 | 27.6 | 35.7 | 55.0 |
| Cash conversion cycle (days) | 30.0 | 79.6 | 78.7 | 88.8 | 151.3 | 12.0 | 70.8 | 80.2 | 78.1 | 91.7 |
| Receivables turnover | 4.38 | 3.30 | 3.73 | 4.47 | 3.83 | 5.91 | 6.03 | 5.95 | 5.83 | 4.95 |
| Payables turnover | 6.84 | 11.76 | 19.08 | 16.34 | 11.07 | 7.35 | 9.57 | 13.23 | 10.23 | 6.64 |
| Inventory turnover | — | — | 13,395,000.00 | 12.37 | 4.10 | — | 7.55 | 7.86 | 7.12 | 5.01 |
| Asset turnover | 0.46 | 0.44 | 0.40 | 0.40 | 0.39 | 0.65 | 0.65 | 0.62 | 0.59 | 0.53 |
| Average receivables | $4.1M | $6.8M | $6.7M | $3.9M | $3.0M | $3.5M | $3.7M | $4.1M | $4.6M | $5.7M |
| Average payables | $1.4M | $939,500 | $702,000 | $525,000 | $514,000 | $1.0M | $850,500 | $768,762 | $1.1M | $1.7M |
| Average inventory | — | — | $1 | $693,500 | $1.4M | — | $1.1M | $1.3M | $1.6M | $2.3M |
| Intangibles / total assets | 80.3% | 74.6% | 71.1% | 73.5% | 66.5% | 76.6% | 72.2% | 69.2% | 65.1% | 60.7% |
Computed from STRM's annual financial statements (latest annual report filed May 2, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
STRM valuation and financial ratios
Streamline Health Solutions earned a return on equity of −65.4% and a return on invested capital of −25.7% in fiscal 2025. It ended the year with $13.1 million of debt and $2.2 million in cash and short-term investments, net debt of $10.9 million. The share count rose 221.8% from 1.2M to 4.0M over 9 years.
See the STRM income statement, the STRM chart for price history, or the STRM stock overview for the latest quote and news.
STRM key metrics FAQ
What is Streamline Health Solutions's return on equity?
Streamline Health Solutions's return on equity (ROE) was −65.4% in fiscal 2025: net income of -$10.2 million on average shareholders' equity of $15.5 million.
What is Streamline Health Solutions's ROIC?
Streamline Health Solutions's return on invested capital was −25.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Streamline Health Solutions have?
Streamline Health Solutions had total debt of $13.1 million at the end of fiscal 2025, a debt-to-equity ratio of 1.07.
What is Streamline Health Solutions's current ratio?
Streamline Health Solutions's current ratio was 0.25 at the end of fiscal 2025: current assets were 0.25 times current liabilities.